内脏保护层在开腹治疗继发性腹膜炎中预防肠空气瘘的意义:倾向性评分匹配病例对照分析
本研究基于两个三级转诊中心的前瞻性开腹治疗数据库,纳入120例因空腔脏器穿孔或吻合口漏导致继发性腹膜炎并接受开腹治疗的患者,通过倾向性评分匹配比较使用与不使用内脏保护层(VPL)对肠空气瘘(EAF)形成的影响。匹配后每组34例,VPL组EAF形成率2.9%,对照组26.5%(P=0.00);回归分析显示VPL显著降低EAF风险(OR 0.08,95%CI 0.01-0.71,P=0.02),相对风险降低89.1%。结论推荐在标准化开腹治疗流程中常规使用VPL。
要点
- VPL组EAF形成率2.9%,显著低于对照组26.5%(P=0.00)。
- VPL使用使EAF风险显著降低(OR 0.08,95%CI 0.01-0.71,P=0.02)。
- 推荐在标准化开腹治疗流程中常规使用VPL。
核心结论
- VPL在腹膜炎患者开腹治疗中有效预防肠空气瘘形成,推荐作为标准化开腹治疗流程的一部分常规使用。
研究设计与样本
- 基于两个三级转诊中心的前瞻性开腹治疗数据库,纳入120例继发性腹膜炎(空腔脏器穿孔或吻合口漏所致)接受开腹治疗的患者,记录14项临床参数。
- 按是否使用VPL分为治疗组和对照组,采用倾向性评分匹配,匹配变量包括恶性肿瘤、死亡率、急诊手术、开腹治疗持续时间和筋膜关闭。
- 匹配后每组34例,使用逻辑回归分析评估VPL对EAF形成的影响。
主要发现
- 匹配后两组在年龄、性别、基础疾病、死亡率、急诊手术、筋膜关闭和开腹治疗持续时间方面无显著差异。
- 总体死亡率为22.1%,平均开腹治疗持续时间约9天,超过三分之二的患者实现二期筋膜关闭,超过75%的病例使用筋膜牵引。
- EAF形成在对照组显著更频繁(VPL组2.9% vs 对照组26.5%,P=0.00)。
- 最终回归分析显示使用VPL显著降低EAF形成风险(OR 0.08,95%CI 0.01-0.71,P=0.02),相对风险降低89.1%。
临床怎么用
- 在继发性腹膜炎患者的开腹治疗中,应常规使用内脏保护层以降低肠空气瘘形成风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the influence of a visceral protective layer (VPL) on the formation of enteroatmospheric fistulae (EAF) in open abdomen treatment (OAT) for peritonitis. BACKGROUND: EAF formation is a severe complication of OAT. Despite the widespread use of OAT, there are no robust evidence-based recommendations for preventing EAF. METHODS: A total of 120 peritonitis patients with secondary peritonitis as a result of a perforation of a hollow viscus or anastomotic insufficiency who had undergone OAT were included, and 14 clinical parameters were recorded in prospective OAT databases at 2 tertiary referral centers. For this analysis, patients with a VPL were assigned to the treatment group and those without a VPL to the control group. Propensity Score (PS) matching was performed. Known risk factors in OAT such as malignant disease, mortality, emergency operation, OAT duration, and fascial closure were matching variables. The influence of VPL on EAF formation was statistically evaluated using logistic regression analysis. RESULTS: With 34 patients in each group, no notable differences were identified with regard to age, sex, underlying disease, mortality, emergency operation, fascial closure, and OAT duration. Overall, a mortality rate of 22.1% for OAT due to peritonitis was observed. Mean OAT duration was approximately 9 days, and secondary fascial closure was achieved in more than two-thirds of all patients. Fascial traction was used in more than 75% of cases. EAF formation was significantly more frequent in the control group (EAF formation: VPL group 2.9% vs control 26.5%; P = 0.00). In the final regression analysis, the use of VPL resulted in a significant reduction in the risk of EAF formation (odds ratio 0.08; 95% confidence interval 0.01-0.71, P = 0.02), which translates to a relative risk reduction of 89.1%. CONCLUSION: VPL effectively prevents EAF formation during OAT in patients with peritonitis. We recommend the consistent use of VPL as part of a standardized OAT treatment algorithm.
引用
- Willms AG, Schaaf S, Zimmermann N, et al. The Significance of Visceral Protection in Preventing Enteroatmospheric Fistulae During Open Abdomen Treatment in Patients With Secondary Peritonitis: A Propensity Score-matched Case-control Analysis. Ann Surg. 2021. PMID: 31318792. doi:10.1097/SLA.0000000000003440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。